1207203-37-9 Usage
General Description
1-((benzyloxy)carbonyl)-3-phenylazetidine-3-carboxylic acid is a chemical compound that belongs to the class of azetidines. It consists of a phenyl group attached to a five-membered azetidine ring, which is further attached to a carboxylic acid group and a benzyloxy carbonyl group. 1-((benzyloxy)carbonyl)-3-phenylazetidine-3-carboxylic acid has potential applications in medicinal chemistry and drug development due to its structural features and potential biological activities. The presence of the carboxylic acid and phenyl groups in the molecule suggests possible interactions with enzymes and receptors in biological systems, making it a promising candidate for pharmaceutical research. Additionally, the benzyloxy carbonyl group could serve as a protective group in chemical synthesis, enabling the selective modification of the azetidine ring. Overall, 1-((benzyloxy)carbonyl)-3-phenylazetidine-3-carboxylic acid presents a versatile and interesting chemical structure with the potential for various applications in organic and medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 1207203-37-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,7,2,0 and 3 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1207203-37:
(9*1)+(8*2)+(7*0)+(6*7)+(5*2)+(4*0)+(3*3)+(2*3)+(1*7)=99
99 % 10 = 9
So 1207203-37-9 is a valid CAS Registry Number.
1207203-37-9Relevant articles and documents
COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY
-
, (2016/12/22)
The present invention relates to compounds acting both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists, to processes for their preparation, to compositions comprising them, to therapeutic uses and combinations with other pharmaceutical active ingredients.
THIOPHENE-2-CARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
-
Page/Page column 27, (2011/08/06)
The subject matter of the invention is compounds corresponding to formula (I), in which: R1 and R2, together with the nitrogen atom to which they are attached, constitute a saturated heterocyclic radical containing from 4 to 7 atoms, which is preferably substituted; one of the two substituents R3 and R6 is a group Y-A-R9; Y is an oxygen atom or an —S(O)n′—, or —OSO2 group; A is an unsubstituted (C1-C4) alkylene group; R9 is an —OR19, —CH3, —NR19R20, —CONR19R20, —NR15COR19, —S(O)nR21, or —NR13SO2R21 group; —R10 is a hydrogen atom or a (C1-C4) alkyl group. The present invention also relates to the methods of preparation and the therapeutic uses of the compounds of formula (I).
